PerkinElmer to Acquire Evotec Technologies


PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to regulatory approvals and other customary closing conditions, and is targeted to be completed in the first quarter of 2007.

Through this acquisition, PerkinElmer will provide its customers in the pharmaceutical, biotechnology and academic arenas with Evotec Technologies' high content screening (HCS) instruments and software.

Other news from the department business & finance

Most read news

More news from our other portals